|
BIOSENSE WEBSTER INC LASSO® NAV ECO VARIABLE CATHETER; CATHETER, ELECTRODE RECORDING OR PROBE, ELECTRODE RECORDING
|
Back to Search Results |
|
| Catalog Number |
D134302 |
| Medical Device Problem Code |
Contamination /Decontamination Problem (2895)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
01/31/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
E 1.Initial reporter address line 1 (cont.): (b)(6).If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
| |
|
Event or Problem Description
|
|
It was reported that a patient underwent a cardiac ablation procedure with a lasso® nav eco variable catheter and the product was full of blood on the outside.A request for clarification is being requested.However, no further information has been made available at this time.
|
| |
|
Additional Manufacturer Narrative
|
|
The device investigation has been completed which included performing a manufacturing record evaluation (mre).The manufacturing record evaluation was performed for the finished device number lot 30738647l and no internal action related to the complaint was found during the review.Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.However, if the product is received at a later date, the investigation will be updated as applicable.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
The biosense webster, inc.Product analysis lab received the device for evaluation.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
It was reported that a patient underwent a cardiac ablation procedure with a lasso® nav eco variable catheter and the product was full of blood on the outside.Device investigation details: the device was returned to johnson & johnson medtech (j&j) for evaluation.A visual inspection and fourier transformed infrared spectroscopy (ft-ir) of the returned device were performed in accordance with j&j procedures.Visual analysis of the returned sample revealed no physical damage or anomalies on the device.It is important to note that the device was received in its original and sealed packaging, which was also placed inside a rubber bag.The rubber bag is not part of the original packaging.As part of the inspection process, the sealed packaging was opened, and no issue was identified during the inspection.However, when the rubber bag was inspected in detail, a foreign material was observed inside the rubber bag.Due to this condition, a fourier transformed infrared spectroscopy (ft-ir) was performed to identify the origin of the foreign material.Based on the spectral analysis and comparison with the cellulose reference, it can be concluded that the unknown sample is primarily composed of cellulose or a cellulose-based material.However, the specific origin of the material remains unknown.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.The foreign material issue reported by the customer was confirmed and is considered as being related to the foreign material that was observed inside the rubber bag.The potential cause of the issues cannot be established.The instructions for use contain (ifu) the following warning and precaution: the sterile packaging and catheter should be inspected prior to use.Do not use the catheter if the packaging or catheter appears damaged.The catheter was sterilized using ethylene oxide and should be used by the use-by date printed on the product label.Do not use the catheter after the date on the product label.The catheter is intended for single use only.Do not re-sterilize and reuse.As part of johnson & johnson medtech's quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
| |
|
Search Alerts/Recalls
|
|
|